Recent challenges faced by Monash IVF have centered primarily around complex legal scrutiny regarding historical genetic testing disclosures, intense competition within the specialized reproductive healthcare sector, and managing operational cost pressures across its clinical network. Additionally, the company has navigated public discussions concerning patient informed consent protocols following high-profile class action settlements, while simultaneously focusing on rebuilding trust, expanding its international clinical footprint, and upgrading its genetic diagnostic laboratory capabilities to maintain industry leadership.